GeoVax Provides Update on Its HIV Vaccine Program
New Clinical Trial Planned With HVTN and NIH Support; Concept Protocol Approved for HVTN 114 ATLANTA, GA - (NewMediaWire) - April 01, 2015 - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines for Ebola and HIV, …